number of events. A meta-analysis was conducted using a random effects or fixed effects model analysis according to the test of heterogeneity.
INTRODUCTION AND OBJECTIVES:
Prior studies have demonstrated high rates of financial strain on men undergoing infertility treatment. The cost and success of testicular surgical sperm retrieval (SSR) in men with nonobstructive azoospermia (NOA) can vary vastly depending on approach, underlying testicular histology, and surgeon experience. We compared cost effectiveness of initial Fine Needle Aspiration mapping (FNAM) with initial microscopic testicular sperm extraction (microTESE).
METHODS: In this cost-effectiveness study, we used decision tree analysis to compare initial FNAM with subsequent SSR vs initial microTESE in the NOA population. This model estimates costs and probability of successful SSR used for In Vitro Fertilization (IVF). Incremental cost-effectiveness ratio (ICER) was the primary value metric. Probabilities of FNAM histological results were based on our institutional series of FNAM in 125 NOA patients. Probabilities of SSR success were abstracted from published literature when available. Out-of-pocket costs were obtained from our billing department. Assumptions in the model include: microTESE occurs with fresh IVF, microTESE success is very low in men with Sertoli-Cell Only histology on FNAM (5%), and few patients (5%) would pursue such treatment. Analysis was performed with TreeAge Pro Healthcare (TreeAge Software, Inc., Williamstown, MA).
RESULTS: The estimated probability of SSR success after initial FNAM was 0.36 vs 0.55 for initial microTESE, yielding an incremental effectiveness of 0.19 for microTESE. The per patient FNAM cost estimate was $11,204, vs $23,000 for initial microTESE, for an incremental cost of $11,795. ICER of microTESE versus FNAM was $62,742.96. One-way sensitivity analysis demonstrated that the ICER is most sensitive to changes in initial microTESE success rates.
CONCLUSIONS: Based on this model, initial FNAM of a man with NOA has lower SSR success, but is more cost-effective than microTESE. When counseling men with NOA, initial FNAM may be more sensible in patients at high risk for financial strain.
Source of Funding: None

PD29-12 USE OF SCROTAL ULTRASOUND FOR EVALUATION OF VARICOCELES: A SURVEY STUDY OF REPRODUCTIVE SPECIALISTS
Mohit Butaney*, Jabez Gondokusumo, Alexander J. Tatem, Jonathan A. Beilan, Nannan Thirumavalavan, Houston, TX; Alexander W. Pastuszak, Salt Lake City, UT; Larry I. Lipshultz, Houston, TX INTRODUCTION AND OBJECTIVES: Ultrasound (US) is commonly utilized by urologists for its ability to noninvasively detect pathology with minimal cost. We aim to assess practice patterns of male reproductive urologists using US to evaluate varicoceles.
METHODS: An IRB-approved anonymous survey was sent to members of Society for Male Reproduction and Urology (SMRU). The survey included questions on respondent demographics, including practice location and type. We asked respondents about their protocols for scrotal US, specifically regarding evaluation of varicoceles. Responses were collected and tabulated using Survey Monkey (San Mateo, California, USA). Chi-square test was used to determine association between categorical variables. RESULTS: Of the 320 people who were sent the survey, 101 (31.6%) responded. Of these, 62 reported using or performing scrotal US and completed the survey. Respondents (93.4%) were attending urologists or resident/fellow urologists (6.6%) practicing in the USA (85.5%), with 87.1% having completed a fellowship in Andrology/Sexual Medicine/ Male Infertility. Of the cohort, 38.7% perform their own ultrasounds compared to the remainder who have either the radiology department or a technician performing the US. When performing their own US, 84% of respondents measure venous diameters for varicoceles, compared to 76% when a 3rd party is performing the US. For those not performing their own ultrasound, 1.8% were unsure whether the US technician looks for varicoceles, 8.9% were unsure whether venous diameters were measured in varicoceles, and 16.1% were unsure of patient position (standing vs supine, Valsalva or not) during the US. A high degree of variability was observed in venous diameter defining a varicocele (range 2-4 mm). In addition, comments made by respondents included 'For radiology, any vein that dilates with Valsalva and has retrograde flow or is 3mm or larger', 'any vein is called a varicocele', and 'change in baseline > 2mm with Valsalva.' Though 80% of respondents assess retrograde flow during the US, only 54% reported that retrograde flow was required to diagnose a varicocele (p<0.01).
CONCLUSIONS: Providers use a wide range of radiographic diagnostic criteria for varicoceles. This variability limits both our ability to determine what truly represents a varicocele and warrants repair, as well as our ability to objectively evaluate the varicocele literature. Further research should focus on standardizing definitions of varicoceles detected by US.
Source of Funding:
This work is supported in part by NIH grant K12 DK0083014, the Multidisciplinary K12 Urologic Research (KURe) Career Development Program (NT is a K12 Scholar).
